PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Drexel researchers develop new DNA test for personalized treatment of bacterial vaginosis

2025-03-28
(Press-News.org) Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial vaginosis (BV) during their lifetime. BV is characterized by unpleasant odors, and potentially painful side effects, as well as the risk of associated health issues later in life. More than half of the patients who seek medical care do not respond to the first-line treatment, the antibiotic metronidazole, leading to recurrence.

Now Drexel researchers have developed a simple DNA PCR-based lab test — built on a more detailed genetic analysis of the main group of bacterial organisms that cause the infection — to help clinicians prescribe the right medicine for each patient. The results are published this week in the journal Genome Medicine.  

“If this test becomes available to patients, they can avoid taking the wrong antibiotic, avoiding additional potential side effects and financial costs,” said lead author Katherine Innamorati, PhD, an instructor in Drexel University College of Medicine. “Faster treatment and better antibiotic stewardship is especially important for patients who may need to take multiple courses of antibiotics to fully eliminate the infection.” 

The main bacterial pathogens associated with BV are a group of related bacterial species previously known as Gardnerella vaginalis. Earlier work by Garth Ehrlich, PhD, a professor of Microbiology and Immunology in the College of Medicine, and colleagues revealed that this group is actually composed of multiple species. 

In the current paper, the authors built out this “family tree” much further. Using genome sequencing and genomic metrics on 129 Gardnerella spp. genomes, the team performed a detailed analysis revealing much greater diversity, including identifying 11 unique groups of organisms known as genospecies, which fall within  several major clades, or groupings. 

Using this data, the research team found that two of the clades are composed of five genospecies that are 100% resistant to metronidazole, but can be successfully treated with the antibiotic clindamycin. Both drugs are typically taken for a week and can be administered vaginally or by mouth. The team’s PCR test can distinguish among the strains, identifying ones that are highly resistant to metronidazole.  

Symptomatic patients can experience vaginal itching, burning during urination, foul odor or gray, white or green discharge. BV is not considered a strictly sexually transmitted infection, but some sexual activities, including not using a condom, and other activities can increase the likelihood of developing BV.  

An estimated half of BV cases show no noticeable symptoms, leading to many cases going untreated. Although about 30% of BV cases resolve without treatment, those with untreated cases may be at higher risk of sexually transmitted infections, greater likelihood of pregnancy complications and other negative impacts to quality of life resulting from inflammation of the mucosa in the reproductive tract.  

“BV is a dysbiosis, meaning the whole microbiome of the lower reproductive tract is imbalanced,” said Ehrlich. “It’s possible that some patients may need both drugs -- metronidazole might provide coverage for some microorganisms, particularly anerobic bacteria that grow in the absence of oxygen. So those with metronidazole resistant Gardnerella might benefit from treatment using both antibiotic drugs, but more research is needed to find out.” 
 
The researchers have filed for a patent for the test. A commercial lab would be needed to offer this widely to patients. Demand from patients and patient support groups may help influence when such a test would become available. Right now, the test can help rule out metronidazole treatment based on highly resistant strains, and the team aims to expand its capabilities to also identify strains that have low resistance to metronidazole. 

The team is also working on determining what gene(s) cause a resistant phenotype.  

“It’s possible that expression of a gene could play a role in the resistance to an antibiotic, or help explain one aspect of how that resistance occurs, but our data suggests metronidazole resistance happens through multiple mechanisms, rather than one clear pattern,” said Ehrlich. “Much work remains to more fully understand the mechanisms by which different groups of genetic organisms become resistant to metronidazole.” 

New randomized controlled trial data published this month in the New England Journal of Medicine suggested that women with BV who are in a monogamous relationship with a male partner may have a lower likelihood of BV coming back after 12 weeks if she takes the first line antibiotics while her male partner also takes the antibiotic and applies a topical antimicrobial clindamycin cream.  

Additional authors on the study include Joshua P. Earl, Shirley C. Barrera, Rachel L. Ehrlich, Josephine Aiyeku, and Ari Gordon of Drexel, Evan Powell of University of Pittsburgh Medical Center, Adam C. Retchless of Allegheny Singer Research Institute, Azad Ahmed, Bhaswati Sen, Sergey Balashov, and Joshua Chang Mell of Drexel, and Sharon L. Hillier of the University of Pittsburgh. 

Read the full study here: https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-025-01446-4.

END


ELSE PRESS RELEASES FROM THIS DATE:

Keith T. Flaherty, MD, FAACR, elected as American Association for Cancer Research President-Elect for 2025-2026

2025-03-28
PHILADELPHIA – The members of the American Association for Cancer Research (AACR) have elected Keith T. Flaherty, MD, Fellow of the AACR Academy, as the AACR President-Elect for 2025-2026. Flaherty will become President-Elect on Monday, April 28, during the AACR’s Annual Business Meeting of Members at the AACR Annual Meeting 2025 in Chicago, Illinois and will assume the Presidency in April 2026 at the AACR Annual Meeting in San Diego, California. Flaherty is director of clinical cancer research and the Richard Saltonstall Endowed Chair in Oncology at Mass General Cancer Center, ...

Brownie points for ChatGPT’s food analysis skills

2025-03-28
URBANA, Ill. — AI is changing the way we work, create, and share information — but brownies? A new study from the University of Illinois Urbana-Champaign explores how ChatGPT can be used in the sensory evaluation of foods, specifically brownies. The study offers insights that could streamline development of new products, and possibly enhance recipes moving forward.  But, why use AI for brownie tasting? Most people would gladly line up to sample chocolatey treats. However, in the food industry, sensory evaluation is an essential yet rigorous and costly process. Companies ...

The Giants Foundation provide 12 schools with CPR resources to improve cardiac emergency outcomes

2025-03-28
NEW JERSEY, March 27, 2025 — The American Heart Association and The Giants Foundation, the nonprofit organization of the New York Giants, gathered representatives from 12 local schools for cardiopulmonary resuscitation (CPR) and automated external defibrillator (AED) training on March 20 at MetLife Stadium. According to American Heart Association data, nearly 9 out of 10 people who experience cardiac arrest outside of a hospital die, in part because they do not receive immediate CPR more than half of the time. CPR, especially if performed immediately, can double or triple a person’s chance of survival. “Early recognition and action in a cardiac emergency ...

Why scientists are worried about weasels

Why scientists are worried about weasels
2025-03-28
When monitoring the health of mammal populations, scientists often use camera traps to observe the animals in their habitats.  But weasels are so sneaky they’re rarely caught on camera – leaving scientists with questions about this population of predators. “We’re a little worried about the weasels,” says Roland Kays, a research professor at North Carolina State University and scientist at the N.C. Museum of Natural Sciences. “We don’t see them very often, but it’s ...

American College of Cardiology recognizes 21 Distinguished Award recipients

2025-03-28
The American College of Cardiology is proud to announce the recipients of the 2025 Distinguished Awards. The twenty-one recipients have made remarkable contributions to the cardiovascular professional, helping the ACC in its mission to transform cardiovascular care and improve heart health for all. Awardees will be recognized during Convocation at the American College of Cardiology’s Annual Scientific Session (ACC.25) taking place March 29 – 31, 2025, in Chicago. The 2025 Distinguished Award winners are: 2025 Bernadine Healy Leadership in Women’s Cardiovascular Disease Malissa J. Wood, MD, FACC 2025 Distinguished Cardiovascular ...

American College of Cardiology recognizes three recipients of the Hani Najm Global Scholar Award Observership Program

2025-03-28
The American College of Cardiology will honor three early career cardiologists with the Hani Najm Global Scholar Award Observership Program at ACC's Annual Scientific Session (ACC.25), taking place March 29 – 31, 2025, in Chicago. Established in 2020 at the Saudi Heart Association’s Annual Conference, the Hani Najm Global Award Observership Program encourages and fosters the sharing of knowledge between international cardiology professionals, specifically early career cardiologists in the Middle East and Africa. Through its Observership Program, recipients have the opportunity to ...

DNA helps electronics to leave flatland

DNA helps electronics to leave flatland
2025-03-28
Researchers at Columbia Engineering have for the first time used DNA to help create 3D electronically operational devices with nanometer-size features. "Going from 2D to 3D can dramatically increase the density and computing power of electronics," said corresponding author Oleg Gang, professor of chemical engineering and of applied physics and materials science at Columbia Engineering and leader of the Center for Functional Nanomaterials' Soft and Bio Nanomaterials Group at Brookhaven National Laboratory. The new manufacturing technique could also contribute to the ongoing effort ...

Studying cardiac cells in space to repair heart damage on Earth

2025-03-28
KENNEDY SPACE CENTER (FL), March 28, 2025 – Heart disease remains the leading cause of death in the United States, accounting for one in five deaths. The inability of damaged heart muscle tissue to regenerate makes heart disease difficult to treat, and end-stage heart failure patients have no choice but to join a long list of people waiting for a heart transplant. Researchers from Emory University are working to provide another option for such patients. To do this, the team took their research to a laboratory unlike any on Earth—the International Space Station (ISSInternational Space Station). Chunhui ...

Studies evaluate the health effects of bioactive compounds obtained from plants

Studies evaluate the health effects of bioactive compounds obtained from plants
2025-03-28
Fruits and plant extracts contain bioactive compounds that can help treat or prevent diseases. To characterize and understand their mechanism of action, researchers from universities and research institutions in Brazil and Germany have conducted independent but complementary studies. Some of the results were presented at a lecture session on the future of food and nutrition research on March 25th during FAPESP Week Germany at the Free University of Berlin. According to Ulrich Dobrindt, a professor at the University of Munich in Germany, medicinal plants contain different types of phytochemicals (natural ...

Howard University physicist revisits the computational limits of life and Schrödinger’s essential question in the era of quantum computing

Howard University physicist revisits the computational limits of life and Schrödinger’s essential question in the era of quantum computing
2025-03-28
WASHINGTON, DC – (March 28, 2025) More than 80 years ago, Erwin Schrödinger, a theoretical physicist steeped in the philosophy of Schopenhauer and the Upanishads, delivered a series of public lectures at Trinity College, Dublin, which eventually came to be published in 1944 under the title What is Life? Now, in the 2025 International Year of Quantum Science and Technology, Philip Kurian, a theoretical physicist and founding director of the Quantum Biology Laboratory (QBL) at Howard University in Washington, D.C., has used the laws of quantum mechanics, which Schrödinger postulated, and the QBL’s discovery of cytoskeletal ...

LAST 30 PRESS RELEASES:

WSU researchers develop machine learning model to predict virus reservoirs

Do authoritarian narratives shape Japanese public opinion?

New plesiosaur discovery sheds light on early Jurassic evolution and plausible endemism

Chance discovery improves stability of bioelectronic material used in medical implants, computing and biosensors

Using artificial intelligence to calculate the heart’s biological age through ECG data predicts increased risk of mortality and cardiovascular events

“She loves me, she loves me not”: physical forces encouraged evolution of multicellular life, scientists propose

The hidden superconducting state in NbSe₂: shedding layers, gaining insights

New AI models possible game-changers within protein science and healthcare

Highly accurate blood test diagnoses Alzheimer’s disease, measures extent of dementia

Mind the seismic gap: Understanding earthquake types in Guerrero, Mexico

One hour’s screen use after going to bed increases your risk of insomnia by 59%, scientists find

Canada needs to support health research at home and abroad

Cannabis use disorder among insured pregnant women in the US between 2015-2020

Education system needs overhaul to support school anxiety, psychologists say

Play “humanizes” pediatric care and should be key feature of a child-friendly NHS – report

Stricter oversight needed as financial misconduct drives risk-taking in banking

Cardiac arrest during long-distance running races

Preventable cardiac deaths during marathons are down, Emory study finds

New study finds peripheral artery disease often underdiagnosed and undertreated; opportunity to improve treatments, lower death rates

Use of antidepressant medication linked to substantial increase in risk of sudden cardiac death 

Atrial fibrillation diagnosed in midlife is linked to a 21% increased risk of dementia at any age and a 36% higher risk of early-onset dementia 

Mode of death in patients with heart failure with mildly reduced or preserved ejection fraction

Intravenous ferric carboxymaltose in heart failure with iron deficiency

Artificial intelligence in the prevention of sudden death

Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes

Prothrombin complex concentrate vs frozen plasma for coagulopathic bleeding in cardiac surgery

Who needs a statin? New study compares prescribing recommendations based on traditional risk factors vs. coronary artery calcium scoring

Finerenone and atrial fibrillation in heart failure

Low coronary artery calcium score is associated with an excellent prognosis regardless of a person’s age, new study finds

Groundbreaking consensus statement on conduction system pacing released: a major milestone in the evolution of pacing therapy

[Press-News.org] Drexel researchers develop new DNA test for personalized treatment of bacterial vaginosis